speb/financial-data huggingface dataset:
ACS.MC cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -376983000.00
ACS.MC income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -305831000.00
ACS.MC cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -750600000.00
ACS.MC cash_flow (annual, 2022-12-31) — Net Other Investing Changes: -57000.00
ACS.MC balance_sheet (annual, 2022-12-31) — Net PPE: 1853926000.00
ACS.MC cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -209113000.00
ACS.MC balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 2263497000.00
ACS.MC balance_sheet (annual, 2022-12-31) — Non Current Deferred Revenue: 2039000.00
ACS.MC balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 839267000.00
ACS.MC balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 294346000.00
ACS.MC income_statement (annual, 2022-12-31) — Normalized EBITDA: 1098390000.00
ACS.MC income_statement (annual, 2022-12-31) — Normalized Income: -69049241.00
ACS.MC cash_flow (annual, 2022-12-31) — Operating Cash Flow: 1743338000.00
ACS.MC income_statement (annual, 2022-12-31) — Operating Income: 277765000.00
ACS.MC income_statement (annual, 2022-12-31) — Operating Revenue: 33615234000.00
ACS.MC balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 258259940.00
ACS.MC balance_sheet (annual, 2022-12-31) — Other Current Assets: 226771000.00
ACS.MC balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 336288000.00
ACS.MC balance_sheet (annual, 2022-12-31) — Other Equity Interest: -13437000.00
ACS.MC balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 567702000.00
ACS.MC balance_sheet (annual, 2022-12-31) — Other Inventories: 74564000.00
ACS.MC cash_flow (annual, 2022-12-31) — Other Non Cash Items: 305783000.00
ACS.MC balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 185757000.00
ACS.MC income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -277597000.00
ACS.MC income_statement (annual, 2022-12-31) — Other Operating Expenses: 2272551000.00
ACS.MC balance_sheet (annual, 2022-12-31) — Other Payable: 5898483000.00
ACS.MC balance_sheet (annual, 2022-12-31) — Other Properties: 673041000.00
ACS.MC balance_sheet (annual, 2022-12-31) — Other Receivables: 1189888000.00
ACS.MC balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 997011000.00
ACS.MC income_statement (annual, 2022-12-31) — Other Special Charges: -810440000.00
ACS.MC income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 0.00
ACS.MC balance_sheet (annual, 2022-12-31) — Payables: 13192884000.00
ACS.MC income_statement (annual, 2022-12-31) — Pretax Income: 1008651000.00
ACS.MC balance_sheet (annual, 2022-12-31) — Properties: 0.00
ACS.MC cash_flow (annual, 2022-12-31) — Purchase Of Business: -452476000.00
ACS.MC cash_flow (annual, 2022-12-31) — Purchase Of Investment: -35278000.00
ACS.MC cash_flow (annual, 2022-12-31) — Purchase Of PPE: -285175000.00
ACS.MC balance_sheet (annual, 2022-12-31) — Raw Materials: 353696000.00
ACS.MC income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 23364723000.00
ACS.MC income_statement (annual, 2022-12-31) — Reconciled Depreciation: 620750000.00
ACS.MC cash_flow (annual, 2022-12-31) — Repayment Of Debt: -4080176000.00
ACS.MC cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -2294674000.00
ACS.MC balance_sheet (annual, 2022-12-31) — Restricted Cash: 0.00
ACS.MC balance_sheet (annual, 2022-12-31) — Retained Earnings: 668227000.00
ACS.MC cash_flow (annual, 2022-12-31) — Sale Of Business: 484327000.00
ACS.MC cash_flow (annual, 2022-12-31) — Sale Of Investment: 14498000.00
ACS.MC cash_flow (annual, 2022-12-31) — Sale Of PPE: 76062000.00
ACS.MC balance_sheet (annual, 2022-12-31) — Share Issued: 284164594.00
ACS.MC income_statement (annual, 2022-12-31) — Special Income Charges: 692218000.00
ACS.MC balance_sheet (annual, 2022-12-31) — Stockholders Equity: 5547396000.00
ACS.MC balance_sheet (annual, 2022-12-31) — Tangible Book Value: 2263497000.00
ACS.MC income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 247267759.00
ACS.MC income_statement (annual, 2022-12-31) — Tax Provision: 201200000.00
ACS.MC income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.27
ACS.MC balance_sheet (annual, 2022-12-31) — Taxes Receivable: 175196000.00
ACS.MC cash_flow (annual, 2022-12-31) — Taxes Refund Paid: -26047000.00
ACS.MC balance_sheet (annual, 2022-12-31) — Total Assets: 37580300000.00
ACS.MC balance_sheet (annual, 2022-12-31) — Total Capitalization: 14352933000.00
ACS.MC balance_sheet (annual, 2022-12-31) — Total Debt: 10996610000.00
ACS.MC balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 6375877000.00
ACS.MC income_statement (annual, 2022-12-31) — Total Expenses: 33337469000.00
ACS.MC balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 31204423000.00
ACS.MC balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 12420992000.00
ACS.MC balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 11484229000.00
ACS.MC income_statement (annual, 2022-12-31) — Total Other Finance Cost: 96000000.00
ACS.MC balance_sheet (annual, 2022-12-31) — Total Tax Payable: 168401000.00
ACS.MC income_statement (annual, 2022-12-31) — Total Unusual Items: 919211000.00
ACS.MC income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 919211000.00
ACS.MC balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 25904654.00
ACS.MC balance_sheet (annual, 2022-12-31) — Treasury Stock: 622170000.00
ACS.MC balance_sheet (annual, 2022-12-31) — Work In Process: 213064000.00
ACS.MC balance_sheet (annual, 2022-12-31) — Working Capital: 5439114000.00
ACS.MC income_statement (annual, 2022-12-31) — Write Off: 428000.00
ACS.MC income_statement (annual, 2023-12-31) — +Operating Expense: 10446996000.00
ACS.MC income_statement (annual, 2023-12-31) — +Total Revenue: 35737759000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Accounts Payable: 7251923000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Accounts Receivable: 7920935000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -2735745000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 366379000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -162612000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Assets Held For Sale Current: 2213847000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 35676000.00
ACS.MC income_statement (annual, 2023-12-31) — Basic Average Shares: 275601590.00
ACS.MC income_statement (annual, 2023-12-31) — Basic EPS: 2.83
ACS.MC cash_flow (annual, 2023-12-31) — Beginning Cash Position: 9419987000.00
ACS.MC cash_flow (annual, 2023-12-31) — Capital Expenditure: -495532000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 703731000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Capital Stock: 139082000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 9087289000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 10049189000.00
ACS.MC cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -394458000.00
ACS.MC cash_flow (annual, 2023-12-31) — Change In Working Capital: -72652000.00
ACS.MC cash_flow (annual, 2023-12-31) — Changes In Cash: -166267000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Common Stock: 139082000.00
ACS.MC cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -394458000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Common Stock Equity: 5329419000.00
ACS.MC cash_flow (annual, 2023-12-31) — Common Stock Issuance: 18248000.00
ACS.MC cash_flow (annual, 2023-12-31) — Common Stock Payments: -1081954000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Construction In Progress: 630684000.00
ACS.MC income_statement (annual, 2023-12-31) — Cost Of Revenue: 24452185000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Current Assets: 23583166000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 160569000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Current Debt: 1455775000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 1616344000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Current Liabilities: 19589491000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Current Provisions: 1119230000.00
ACS.MC cash_flow (annual, 2023-12-31) — Depreciation: 551019000.00
ACS.MC cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 551019000.00
ACS.MC income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 551019000.00
ACS.MC income_statement (annual, 2023-12-31) — Depreciation Income Statement: 551019000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Derivative Product Liabilities: 30373000.00
ACS.MC income_statement (annual, 2023-12-31) — Diluted Average Shares: 275601590.00
ACS.MC income_statement (annual, 2023-12-31) — Diluted EPS: 2.83
ACS.MC income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 780123000.00
ACS.MC cash_flow (annual, 2023-12-31) — Dividend Received Cfo: 929358000.00
ACS.MC income_statement (annual, 2023-12-31) — EBIT: 1707229000.00
ACS.MC income_statement (annual, 2023-12-31) — EBITDA: 2258248000.00
ACS.MC cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: -166431000.00
ACS.MC cash_flow (annual, 2023-12-31) — End Cash Position: 9087289000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Financial Assets: 84269000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 252311000.00
ACS.MC cash_flow (annual, 2023-12-31) — Financing Cash Flow: -1652857000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Finished Goods: 191434000.00
ACS.MC cash_flow (annual, 2023-12-31) — Free Cash Flow: 1006805000.00
ACS.MC cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: -422436000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Goodwill: 2734491000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 3281559000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 8083547000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Gross PPE: 4551909000.00
ACS.MC income_statement (annual, 2023-12-31) — Gross Profit: 11285574000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Hedging Assets Current: 528047000.00
ACS.MC income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: -41011000.00
ACS.MC income_statement (annual, 2023-12-31) — Interest Expense: 580000000.00
ACS.MC income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 580000000.00
ACS.MC income_statement (annual, 2023-12-31) — Interest Income: 302408000.00
ACS.MC income_statement (annual, 2023-12-31) — Interest Income Non Operating: 302408000.00
ACS.MC cash_flow (annual, 2023-12-31) — Interest Paid Cfo: -650564000.00
ACS.MC cash_flow (annual, 2023-12-31) — Interest Received Cfo: 284555000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Inventory: 790004000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Invested Capital: 15017697000.00
ACS.MC cash_flow (annual, 2023-12-31) — Investing Cash Flow: -15747000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Investment Properties: 66557000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 287987000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Investmentsin Associatesat Cost: 4292279000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Investmentsin Joint Venturesat Cost: 1496631000.00
ACS.MC cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 18248000.00
ACS.MC cash_flow (annual, 2023-12-31) — Issuance Of Debt: 3776770000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Land And Improvements: 1396894000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 543162000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Long Term Debt: 8232503000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 8775665000.00
ACS.MC cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 3776770000.00
ACS.MC cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -3548723000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 5788910000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Long Term Provisions: 1888979000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 1828973000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Minority Interest: 301152000.00
ACS.MC income_statement (annual, 2023-12-31) — Minority Interests: -148022000.00
ACS.MC cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 416947000.00
ACS.MC cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -1063706000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Net Debt: 600989000.00
ACS.MC income_statement (annual, 2023-12-31) — Net Income: 780123000.00
ACS.MC income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 780123000.00
ACS.MC income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 928145000.00
ACS.MC income_statement (annual, 2023-12-31) — Net Income Discontinuous Operations: 0.00
ACS.MC income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 780123000.00
ACS.MC income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 780123000.00
ACS.MC cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 1127229000.00
ACS.MC income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 928145000.00
ACS.MC income_statement (annual, 2023-12-31) — Net Interest Income: -356692000.00
ACS.MC cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -5809000.00
ACS.MC cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 228047000.00
ACS.MC cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 228047000.00
ACS.MC income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -356692000.00
ACS.MC cash_flow (annual, 2023-12-31) — Net Other Financing Charges: 21242000.00
ACS.MC cash_flow (annual, 2023-12-31) — Net Other Investing Changes: -267000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Net PPE: 1816164000.00
ACS.MC cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -426618000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 2047860000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Non Current Deferred Revenue: 1775000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 851421000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 331991000.00
ACS.MC income_statement (annual, 2023-12-31) — Normalized EBITDA: 1873966000.00
ACS.MC income_statement (annual, 2023-12-31) — Normalized Income: 501518550.00
ACS.MC cash_flow (annual, 2023-12-31) — Operating Cash Flow: 1502337000.00
ACS.MC income_statement (annual, 2023-12-31) — Operating Income: 838578000.00
ACS.MC income_statement (annual, 2023-12-31) — Operating Revenue: 35737759000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 260606194.00
ACS.MC balance_sheet (annual, 2023-12-31) — Other Current Assets: 355389000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 441997000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 547068000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Other Inventories: 47150000.00
ACS.MC cash_flow (annual, 2023-12-31) — Other Non Cash Items: 356733000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 180441000.00
ACS.MC income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: -155192000.00
ACS.MC income_statement (annual, 2023-12-31) — Other Operating Expenses: 2224849000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Other Payable: 6856908000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Other Properties: 695358000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Other Receivables: 1384768000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 961900000.00
ACS.MC income_statement (annual, 2023-12-31) — Other Special Charges: -334884000.00
ACS.MC income_statement (annual, 2023-12-31) — Otherunder Preferred Stock Dividend: 0.00
ACS.MC balance_sheet (annual, 2023-12-31) — Payables: 14294643000.00
ACS.MC income_statement (annual, 2023-12-31) — Pretax Income: 1127229000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Properties: 0.00
ACS.MC cash_flow (annual, 2023-12-31) — Purchase Of Business: -1452810000.00
ACS.MC cash_flow (annual, 2023-12-31) — Purchase Of Investment: -16748000.00
ACS.MC cash_flow (annual, 2023-12-31) — Purchase Of PPE: -495532000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Raw Materials: 339911000.00
ACS.MC income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 24452185000.00
ACS.MC income_statement (annual, 2023-12-31) — Reconciled Depreciation: 551019000.00
ACS.MC cash_flow (annual, 2023-12-31) — Repayment Of Debt: -3548723000.00
ACS.MC cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -1081954000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Retained Earnings: 780123000.00
ACS.MC cash_flow (annual, 2023-12-31) — Sale Of Business: 1869757000.00
ACS.MC cash_flow (annual, 2023-12-31) — Sale Of Investment: 10939000.00
ACS.MC cash_flow (annual, 2023-12-31) — Sale Of PPE: 68914000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Share Issued: 278164594.00
ACS.MC income_statement (annual, 2023-12-31) — Special Income Charges: -38154000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Stockholders Equity: 5329419000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Tangible Book Value: 2047860000.00
ACS.MC income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 105677550.00
ACS.MC income_statement (annual, 2023-12-31) — Tax Provision: 199084000.00
ACS.MC income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.28
ACS.MC balance_sheet (annual, 2023-12-31) — Taxes Receivable: 340987000.00
ACS.MC cash_flow (annual, 2023-12-31) — Taxes Refund Paid: -305963000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Total Assets: 36498270000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Total Capitalization: 13561922000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Total Debt: 10392009000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 5630571000.00
ACS.MC income_statement (annual, 2023-12-31) — Total Expenses: 34899181000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 30867699000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 12915104000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 11278208000.00
ACS.MC income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 1136277000.00
ACS.MC income_statement (annual, 2023-12-31) — Total Other Finance Cost: 79100000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Total Tax Payable: 185812000.00
ACS.MC income_statement (annual, 2023-12-31) — Total Unusual Items: 384282000.00
ACS.MC income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 384282000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 17558400.00
ACS.MC balance_sheet (annual, 2023-12-31) — Treasury Stock: 465918000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Work In Process: 211509000.00
ACS.MC balance_sheet (annual, 2023-12-31) — Working Capital: 3993675000.00
ACS.MC income_statement (annual, 2023-12-31) — Write Off: 79165000.00
ACS.MC balance_sheet (quarterly, 2024-09-30) — Cash Financial: 8890000000.00
ACS.MC balance_sheet (quarterly, 2024-09-30) — Liabilities Heldfor Sale Non Current: 1980000000.00
ACS.MC balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 4247000000.00
ACS.MC income_statement (annual, 2024-12-31) — +Operating Expense: 12523948000.00
ACS.MC income_statement (quarterly, 2024-12-31) — +Operating Expense: 6930144000.00
ACS.MC income_statement (annual, 2024-12-31) — +Total Revenue: 41633120000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Accounts Payable: 9386724000.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 9386724000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Accounts Receivable: 9505323000.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Accounts Receivable: 9505323000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -3063683000.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -3063683000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 366379000.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Additional Paid In Capital: 366379000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -149159000.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -149159000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Assets Held For Sale Current: 1686645000.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Assets Held For Sale Current: 1686645000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Available For Sale Securities: 69596000.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Available For Sale Securities: 69596000.00
ACS.MC income_statement (annual, 2024-12-31) — Basic Average Shares: 271394667.00
ACS.MC income_statement (quarterly, 2024-12-31) — Basic Average Shares: 260336018.00
ACS.MC income_statement (annual, 2024-12-31) — Basic EPS: 3.05
ACS.MC income_statement (quarterly, 2024-12-31) — Basic EPS: 1.58
ACS.MC cash_flow (annual, 2024-12-31) — Beginning Cash Position: 9087289000.00
ACS.MC cash_flow (annual, 2024-12-31) — Capital Expenditure: -660851000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 1138678000.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 1138678000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Capital Stock: 135832000.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Capital Stock: 135832000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 11413659000.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 11413659000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 12343146000.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 12343146000.00
ACS.MC cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -368128000.00
ACS.MC cash_flow (annual, 2024-12-31) — Change In Working Capital: 596059000.00
ACS.MC cash_flow (annual, 2024-12-31) — Changes In Cash: 2040951000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Common Stock: 135832000.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Common Stock: 135832000.00
ACS.MC cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -368128000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Common Stock Equity: 4714213000.00
ACS.MC cash_flow (annual, 2024-12-31) — Common Stock Issuance: 1757000.00
ACS.MC cash_flow (annual, 2024-12-31) — Common Stock Payments: -625349000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Construction In Progress: 946457000.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Construction In Progress: 946457000.00
ACS.MC income_statement (annual, 2024-12-31) — Cost Of Revenue: 28284489000.00
ACS.MC income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 15261834000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Current Assets: 26949446000.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Current Assets: 26949446000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 356876000.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 356876000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Current Debt: 2728300000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 3085176000.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 3085176000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Current Liabilities: 23115877000.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Current Liabilities: 23115877000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Current Provisions: 1289638000.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Current Provisions: 1289638000.00
ACS.MC cash_flow (annual, 2024-12-31) — Depreciation: 866203000.00
ACS.MC cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 866203000.00
ACS.MC income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 866203000.00
ACS.MC income_statement (quarterly, 2024-12-31) — Depreciation And Amortization In Income Statement: 516351000.00
ACS.MC income_statement (annual, 2024-12-31) — Depreciation Income Statement: 866203000.00
ACS.MC income_statement (quarterly, 2024-12-31) — Depreciation Income Statement: 516351000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Derivative Product Liabilities: 38414000.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Derivative Product Liabilities: 38414000.00
ACS.MC income_statement (annual, 2024-12-31) — Diluted Average Shares: 271394667.00
ACS.MC income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 260336018.00
ACS.MC income_statement (annual, 2024-12-31) — Diluted EPS: 3.05
ACS.MC income_statement (quarterly, 2024-12-31) — Diluted EPS: 1.58
ACS.MC income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 827580000.00
ACS.MC cash_flow (annual, 2024-12-31) — Dividend Received Cfo: 741731000.00
ACS.MC income_statement (annual, 2024-12-31) — EBIT: 1712640000.00
ACS.MC income_statement (quarterly, 2024-12-31) — EBIT: 892598000.00
ACS.MC income_statement (annual, 2024-12-31) — EBITDA: 2578843000.00
ACS.MC income_statement (quarterly, 2024-12-31) — EBITDA: 1408949000.00
ACS.MC cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: 285419000.00
ACS.MC cash_flow (annual, 2024-12-31) — End Cash Position: 11413659000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Financial Assets: 72677000.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Financial Assets: 72677000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 116590000.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 116590000.00
ACS.MC cash_flow (annual, 2024-12-31) — Financing Cash Flow: 496661000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Finished Goods: 185459000.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Finished Goods: 185459000.00
ACS.MC cash_flow (annual, 2024-12-31) — Free Cash Flow: 2132023000.00
ACS.MC cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 28728000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Goodwill: 4754177000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 5592972000.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Goodwill And Other Intangible Assets: 5592972000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 9654482000.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Gross Accounts Receivable: 9654482000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Gross PPE: 6159145000.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Gross PPE: 6159145000.00
ACS.MC income_statement (annual, 2024-12-31) — Gross Profit: 13348631000.00
ACS.MC income_statement (quarterly, 2024-12-31) — Gross Profit: 7622110000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Hedging Assets Current: 11720000.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Hedging Assets Current: 11720000.00
ACS.MC income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: -515605000.00
ACS.MC income_statement (quarterly, 2024-12-31) — Impairment Of Capital Assets: -182264000.00
ACS.MC income_statement (annual, 2024-12-31) — Interest Expense: 719300000.00
ACS.MC income_statement (quarterly, 2024-12-31) — Interest Expense: 463711000.00
ACS.MC income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 719300000.00
ACS.MC income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 463711000.00
ACS.MC income_statement (annual, 2024-12-31) — Interest Income: 435214000.00
ACS.MC income_statement (quarterly, 2024-12-31) — Interest Income: 168560000.00
ACS.MC income_statement (annual, 2024-12-31) — Interest Income Non Operating: 435214000.00
ACS.MC income_statement (quarterly, 2024-12-31) — Interest Income Non Operating: 168560000.00
ACS.MC cash_flow (annual, 2024-12-31) — Interest Paid Cfo: -830966000.00
ACS.MC cash_flow (annual, 2024-12-31) — Interest Received Cfo: 364204000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Inventory: 1023572000.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Inventory: 1023572000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Invested Capital: 17780238000.00
ACS.MC cash_flow (annual, 2024-12-31) — Investing Cash Flow: -1248584000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Investment Properties: 64466000.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Investment Properties: 64466000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 186186000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Investmentsin Associatesat Cost: 3268782000.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Investmentsin Associatesat Cost: 3268782000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Investmentsin Joint Venturesat Cost: 645378000.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Investmentsin Joint Venturesat Cost: 645378000.00
ACS.MC cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 1757000.00
ACS.MC cash_flow (annual, 2024-12-31) — Issuance Of Debt: 5512897000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Land And Improvements: 1534774000.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Land And Improvements: 1534774000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 781802000.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 781802000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Long Term Debt: 10337725000.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Long Term Debt: 10337725000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 11119527000.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 11119527000.00
ACS.MC cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 5512897000.00
ACS.MC cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -4350251000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 3914160000.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Long Term Equity Investment: 3914160000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Long Term Provisions: 1690644000.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Long Term Provisions: 1690644000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 2911799000.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 2911799000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Minority Interest: 400717000.00
ACS.MC income_statement (annual, 2024-12-31) — Minority Interests: -252239000.00
ACS.MC cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: -1208194000.00
ACS.MC cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -623592000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Net Debt: 1652366000.00
ACS.MC income_statement (annual, 2024-12-31) — Net Income: 827580000.00
ACS.MC income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 827580000.00
ACS.MC income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 1079819000.00
ACS.MC income_statement (annual, 2024-12-31) — Net Income Discontinuous Operations: 0.00
ACS.MC income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 827580000.00
ACS.MC income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 827580000.00
ACS.MC cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 993340000.00
ACS.MC income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 1079819000.00
ACS.MC income_statement (annual, 2024-12-31) — Net Interest Income: -408086000.00
ACS.MC income_statement (quarterly, 2024-12-31) — Net Interest Income: -238921000.00
ACS.MC cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 513322000.00
ACS.MC cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 1162646000.00
ACS.MC cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 1162646000.00
ACS.MC income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -408086000.00
ACS.MC income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -238921000.00
ACS.MC cash_flow (annual, 2024-12-31) — Net Other Financing Charges: 1789296000.00
ACS.MC cash_flow (annual, 2024-12-31) — Net Other Investing Changes: -6399000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Net PPE: 3095462000.00
ACS.MC cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -553712000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Net Tangible Assets: -878759000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Non Current Deferred Revenue: 1824000.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Revenue: 1824000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 1398195000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 461410000.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Liabilities: 461410000.00
ACS.MC income_statement (annual, 2024-12-31) — Normalized EBITDA: 2080897000.00
ACS.MC income_statement (quarterly, 2024-12-31) — Normalized EBITDA: 1416485000.00
ACS.MC income_statement (annual, 2024-12-31) — Normalized Income: 454120500.00
ACS.MC cash_flow (annual, 2024-12-31) — Operating Cash Flow: 2792874000.00
ACS.MC income_statement (annual, 2024-12-31) — Operating Income: 824683000.00
ACS.MC income_statement (quarterly, 2024-12-31) — Operating Income: 691966000.00
ACS.MC income_statement (annual, 2024-12-31) — Operating Revenue: 41633120000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 254798572.00
ACS.MC balance_sheet (annual, 2024-12-31) — Other Current Assets: 342705000.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Other Current Assets: 342705000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 1284435000.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 1284435000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 838795000.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Other Intangible Assets: 838795000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Other Inventories: 57151000.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Other Inventories: 57151000.00
ACS.MC cash_flow (annual, 2024-12-31) — Other Non Cash Items: 408102000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 420575000.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Other Non Current Liabilities: 420575000.00
ACS.MC income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 31123000.00
ACS.MC income_statement (annual, 2024-12-31) — Other Operating Expenses: 2665056000.00
ACS.MC income_statement (quarterly, 2024-12-31) — Other Operating Expenses: 1540536000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Other Payable: 6362441000.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Other Payable: 6362441000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Other Properties: 766115000.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Other Properties: 766115000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Other Receivables: 1581985000.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Other Receivables: 1581985000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 929487000.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Other Short Term Investments: 929487000.00
ACS.MC income_statement (annual, 2024-12-31) — Other Special Charges: -60000000.00
ACS.MC income_statement (quarterly, 2024-12-31) — Other Special Charges: 254515000.00
ACS.MC income_statement (annual, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
ACS.MC balance_sheet (annual, 2024-12-31) — Payables: 15960812000.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Payables: 15960812000.00
ACS.MC income_statement (annual, 2024-12-31) — Pretax Income: 993340000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Properties: 0.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
ACS.MC cash_flow (annual, 2024-12-31) — Purchase Of Business: -1223724000.00
ACS.MC cash_flow (annual, 2024-12-31) — Purchase Of Investment: -35602000.00
ACS.MC cash_flow (annual, 2024-12-31) — Purchase Of PPE: -660851000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Raw Materials: 554291000.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Raw Materials: 554291000.00
ACS.MC income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 28284489000.00
ACS.MC income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 15261834000.00
ACS.MC income_statement (annual, 2024-12-31) — Reconciled Depreciation: 866203000.00
ACS.MC income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 516351000.00
ACS.MC cash_flow (annual, 2024-12-31) — Repayment Of Debt: -4350251000.00
ACS.MC cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -625349000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Retained Earnings: 827580000.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Retained Earnings: 827580000.00
ACS.MC cash_flow (annual, 2024-12-31) — Sale Of Business: 15530000.00
ACS.MC cash_flow (annual, 2024-12-31) — Sale Of Investment: 548924000.00
ACS.MC cash_flow (annual, 2024-12-31) — Sale Of PPE: 107139000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Share Issued: 271664594.00
ACS.MC income_statement (annual, 2024-12-31) — Special Income Charges: 526674000.00
ACS.MC income_statement (quarterly, 2024-12-31) — Special Income Charges: -19530000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Stockholders Equity: 4714213000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Tangible Book Value: -878759000.00
ACS.MC income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 124486500.00
ACS.MC income_statement (annual, 2024-12-31) — Tax Provision: -86479000.00
ACS.MC income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.25
ACS.MC balance_sheet (annual, 2024-12-31) — Taxes Receivable: 454350000.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Taxes Receivable: 454350000.00
ACS.MC cash_flow (annual, 2024-12-31) — Taxes Refund Paid: -332778000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Total Assets: 42025282000.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Total Assets: 42025282000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Total Capitalization: 15051938000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Total Debt: 14204703000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 5114930000.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 5114930000.00
ACS.MC income_statement (annual, 2024-12-31) — Total Expenses: 40808437000.00
ACS.MC income_statement (quarterly, 2024-12-31) — Total Expenses: 22191978000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 36910352000.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 36910352000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 15075836000.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 15075836000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 13794475000.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 13794475000.00
ACS.MC income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 1443333000.00
ACS.MC income_statement (quarterly, 2024-12-31) — Total Operating Income As Reported: 619715000.00
ACS.MC income_statement (annual, 2024-12-31) — Total Other Finance Cost: 124000000.00
ACS.MC income_statement (quarterly, 2024-12-31) — Total Other Finance Cost: -56230000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Total Tax Payable: 211647000.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 211647000.00
ACS.MC income_statement (annual, 2024-12-31) — Total Unusual Items: 497946000.00
ACS.MC income_statement (quarterly, 2024-12-31) — Total Unusual Items: -7536000.00
ACS.MC income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 497946000.00
ACS.MC income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: -7536000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 16866022.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Treasury Shares Number: 16866022.00
ACS.MC balance_sheet (annual, 2024-12-31) — Treasury Stock: 557867000.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Treasury Stock: 557867000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Work In Process: 226671000.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Work In Process: 226671000.00
ACS.MC balance_sheet (annual, 2024-12-31) — Working Capital: 3833569000.00
ACS.MC balance_sheet (quarterly, 2024-12-31) — Working Capital: 3833569000.00
ACS.MC income_statement (annual, 2024-12-31) — Write Off: -11069000.00
ACS.MC income_statement (quarterly, 2024-12-31) — Write Off: -52721000.00
ACS.MC income_statement (quarterly, 2025-03-31) — +Total Revenue: 11790000000.00
ACS.MC income_statement (quarterly, 2025-03-31) — Basic Average Shares: 258357488.00
ACS.MC income_statement (quarterly, 2025-03-31) — Basic EPS: 0.74
ACS.MC cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: -702000000.00
ACS.MC cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -94000000.00
ACS.MC cash_flow (quarterly, 2025-03-31) — Capital Expenditure Reported: -94000000.00
ACS.MC cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -107000000.00
ACS.MC balance_sheet (quarterly, 2025-03-31) — Cash Financial: 9414000000.00
ACS.MC cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -1533000000.00
ACS.MC cash_flow (quarterly, 2025-03-31) — Changes In Cash: -2097000000.00
ACS.MC balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 4404000000.00
ACS.MC cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -5000000.00
ACS.MC balance_sheet (quarterly, 2025-03-31) — Current Debt: 2746000000.00
ACS.MC income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 258357488.00
ACS.MC income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.74
ACS.MC income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 191000000.00
ACS.MC cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: -105000000.00
ACS.MC cash_flow (quarterly, 2025-03-31) — End Cash Position: -2847000000.00
ACS.MC cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -112000000.00
ACS.MC cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -1260000000.00
ACS.MC balance_sheet (quarterly, 2025-03-31) — Goodwill: 5022000000.00
ACS.MC balance_sheet (quarterly, 2025-03-31) — Invested Capital: 7150000000.00
ACS.MC cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -819000000.00
ACS.MC balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 4635000000.00
ACS.MC balance_sheet (quarterly, 2025-03-31) — Liabilities Heldfor Sale Non Current: 1378000000.00
ACS.MC balance_sheet (quarterly, 2025-03-31) — Minority Interest: 327000000.00
ACS.MC income_statement (quarterly, 2025-03-31) — Minority Interests: -59000000.00
ACS.MC cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -5000000.00
ACS.MC balance_sheet (quarterly, 2025-03-31) — Net Debt: 2746000000.00
ACS.MC income_statement (quarterly, 2025-03-31) — Net Income: 191000000.00
ACS.MC income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 191000000.00
ACS.MC income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 251000000.00
ACS.MC income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 191000000.00
ACS.MC income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 191000000.00
ACS.MC cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 699000000.00
ACS.MC income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 251000000.00
ACS.MC cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: -623000000.00
ACS.MC cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: -102000000.00
ACS.MC balance_sheet (quarterly, 2025-03-31) — Net PPE: 4139000000.00
ACS.MC balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 4404000000.00
ACS.MC balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 1316000000.00
ACS.MC income_statement (quarterly, 2025-03-31) — Normalized Income: 191000000.00
ACS.MC cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -1166000000.00
ACS.MC income_statement (quarterly, 2025-03-31) — Operating Revenue: 11790000000.00
ACS.MC balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 249394190.00
ACS.MC cash_flow (quarterly, 2025-03-31) — Other Cash Adjustment Outside Changein Cash: 57000000.00
ACS.MC balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 4404000000.00
ACS.MC income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
ACS.MC income_statement (quarterly, 2025-03-31) — Pretax Income: 353000000.00
ACS.MC cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -5000000.00
ACS.MC balance_sheet (quarterly, 2025-03-31) — Share Issued: 271664594.00
ACS.MC balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 4404000000.00
ACS.MC balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 4404000000.00
ACS.MC income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
ACS.MC income_statement (quarterly, 2025-03-31) — Tax Provision: 102000000.00
ACS.MC income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.29
ACS.MC cash_flow (quarterly, 2025-03-31) — Taxes Refund Paid: -101000000.00
ACS.MC balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 4404000000.00
ACS.MC balance_sheet (quarterly, 2025-03-31) — Total Debt: 2746000000.00
ACS.MC balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 22270404.00
ACS.MC income_statement (quarterly, 2025-06-30) — +Total Revenue: 12318326000.00
ACS.MC balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 9014328000.00
ACS.MC balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 10731036000.00
ACS.MC balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -1361671000.00
ACS.MC balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 366379000.00
ACS.MC balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -119429000.00
ACS.MC balance_sheet (quarterly, 2025-06-30) — Assets Held For Sale Current: 1562412000.00
ACS.MC balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 73643000.00
ACS.MC cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: -2847000000.00
ACS.MC cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -293071000.00
ACS.MC balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 966413000.00
ACS.MC balance_sheet (quarterly, 2025-06-30) — Capital Stock: 135832000.00
ACS.MC balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 9600911000.00
ACS.MC balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 10866256000.00
ACS.MC cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -13340000.00
ACS.MC cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 791860000.00
ACS.MC cash_flow (quarterly, 2025-06-30) — Changes In Cash: 1008201000.00
ACS.MC balance_sheet (quarterly, 2025-06-30) — Common Stock: 135832000.00
ACS.MC balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 4188700000.00
ACS.MC cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -38112000.00